Skip to menu Skip to content Skip to footer

2008

Journal Article

Biomarkers for TB treatment response: Challenges and future strategies

Walzl, Gerhard, Ronacher, Katharina , Djoba Siawaya, Joel Fleury and Dockrell, Hazel M. (2008). Biomarkers for TB treatment response: Challenges and future strategies. Journal of Infection, 57 (2), 103-109. doi: 10.1016/j.jinf.2008.06.007

Biomarkers for TB treatment response: Challenges and future strategies

2008

Journal Article

Differential expression of interleukin-4 (IL-4) and IL-4δ2 mRNA, but not transforming growth factor beta (TGF-β), TGF-βRII, Foxp3, gamma interferon, T-bet, or GATA-3 mRNA, in patients with fast and slow responses to antituberculosis treatment

Siawaya, Joel Fleury Djoba, Bapela, Nchinya Bennedict, Ronacher, Katharina, Beyers, Nulda, Van Helden, Paul and Walzl, Gerhard (2008). Differential expression of interleukin-4 (IL-4) and IL-4δ2 mRNA, but not transforming growth factor beta (TGF-β), TGF-βRII, Foxp3, gamma interferon, T-bet, or GATA-3 mRNA, in patients with fast and slow responses to antituberculosis treatment. Clinical and Vaccine Immunology, 15 (8), 1165-1170. doi: 10.1128/CVI.00084-08

Differential expression of interleukin-4 (IL-4) and IL-4δ2 mRNA, but not transforming growth factor beta (TGF-β), TGF-βRII, Foxp3, gamma interferon, T-bet, or GATA-3 mRNA, in patients with fast and slow responses to antituberculosis treatment

2008

Journal Article

Immune parameters as markers of tuberculosis extent of disease and early prediction of anti-tuberculosis chemotherapy response

Djoba Siawaya, Joel Fleury, Bapela, Nchinya Bennedict, Ronacher, Katharina, Veenstra, Hanne, Kidd, Martin, Gie, Robert, Beyers, Nulda, van Helden, Paul and Walzl, Gerhard (2008). Immune parameters as markers of tuberculosis extent of disease and early prediction of anti-tuberculosis chemotherapy response. Journal of Infection, 56 (5), 340-347. doi: 10.1016/j.jinf.2008.02.007

Immune parameters as markers of tuberculosis extent of disease and early prediction of anti-tuberculosis chemotherapy response

2005

Journal Article

Synthetic progestins used in HRT have different glucocorticoid agonist properties

Koubovec, Dominique, Ronacher, Katharina, Stubsrud, Elisabeth, Louw, Ann and Hapgood, Janet P. (2005). Synthetic progestins used in HRT have different glucocorticoid agonist properties. Molecular and Cellular Endocrinology, 242 (1-2), 23-32. doi: 10.1016/j.mce.2005.07.001

Synthetic progestins used in HRT have different glucocorticoid agonist properties

2005

Journal Article

Regulation of expression of mammalian gonadotrophin-releasing hormone receptor genes

Hapgood, J. P., Sadie, H., van Biljon, W. and Ronacher, K. (2005). Regulation of expression of mammalian gonadotrophin-releasing hormone receptor genes. Journal of Neuroendocrinology, 17 (10), 619-638. doi: 10.1111/j.1365-2826.2005.01353.x

Regulation of expression of mammalian gonadotrophin-releasing hormone receptor genes

2004

Journal Article

Serine residues 338 and 339 in the carboxyl-terminal tail of the type II gonadotropin-releasing hormone receptor are critical for β-arrestin- independent internalization

Ronacher, Katharina, Matsiliza, Nosisa, Nkwanyana, Nonhlanhla, Pawson, Adam J. , Adam, Tasneem, Flanagan, Colleen A. , Millar, Robert P. and Katz, Arieh A. (2004). Serine residues 338 and 339 in the carboxyl-terminal tail of the type II gonadotropin-releasing hormone receptor are critical for β-arrestin- independent internalization. Endocrinology, 145 (10), 4480-4488. doi: 10.1210/en.2004-0075

Serine residues 338 and 339 in the carboxyl-terminal tail of the type II gonadotropin-releasing hormone receptor are critical for β-arrestin- independent internalization